The Mass Spectrometry and Chromatography in Diagnostics Market Size is valued at USD 732.1 Mn in 2023 and is predicted to reach USD 1,613.6 Bn by the year 2031 at an 10.7% CAGR during the forecast period for 2024-2031.
Mass spectrometry (MS) is a powerful analytical technique widely used in clinical settings to identify and quantify clinically relevant analytes, playing a crucial role in diagnosing diseases through biomarkers. Biomarkers, essential for diagnoses, prognoses, and treatment, are analyzed using MS to provide valuable insights into health conditions. Complementing MS, chromatography is a technique used to separate components of a mixture. This process begins by dissolving the mixture in a mobile phase, which then carries it through a stationary phase. Chromatography serves both as an analytical tool, by feeding its output into a detector for analysis, and as a purification tool, by isolating components of a mixture for use in further experiments or procedures.
Modern technologies such as miniature mass spectrometry equipment have the potential to transform point-of-care (POC) diagnostics. These technologies, which are distinguished by their high sensitivity, specificity, and mobility, allow for the quick and precise identification of illnesses In diagnostics, mass spectrometry and chromatography are key tools for applications such as vitamin and hormone profiling, among others. The market for these technologies is expanding rapidly, driven by their advantages over traditional immunoassays and ongoing technological advancements that continue to enhance their adoption and effectiveness. Continuous innovations in mass spectrometry and chromatography technologies enhance their sensitivity, accuracy, and speed, making them more effective and reliable for diagnostics.
The mass spectrometry and chromatography in diagnostics market is segmented based on product type, by application type, by sample type, by testing type. Based on the by-product type, the market is segmented into sample preparation, mass spectrometry, and chromatography. Based on the by application type, the market is segmented into therapeutic drug monitoring, vitamins, hormones, methylmalonic acid, immunosuppressants, and others. Based on the sample type, the market is segmented into blood, urine, serum, plasma, and saliva. Based on the by-testing type, the market is segmented into laboratory-developed tests and commercial assays.
Based on the product type, the market is segmented into sample preparation, mass spectrometry, and chromatography. Among these, The Mass Spectrometry Segment is Expected to have the highest growth rate during the forecast period. Mass spectrometry provides exceptional sensitivity and accuracy in detecting and quantifying analytes, which is critical for precise diagnostics. Ongoing advancements in mass spectrometry technologies, such as miniaturization and improved detection methods, drive its widespread adoption and market dominance. Mass spectrometry is versatile and can be applied to various diagnostic areas, including biomarker discovery, drug testing, and metabolic profiling, enhancing its market appeal. The need for detailed and comprehensive diagnostic data, which mass spectrometry can deliver, supports its leading position in the market.
Based on the by application type, the market is segmented into therapeutic drug monitoring, vitamins, hormones, methylmalonic acid, immunosuppressants, and others. Among these, the therapeutic drug monitoring (TDM) segment dominates the market. TDM is crucial for ensuring that drug levels remain within the therapeutic range, optimizing patient treatment, and minimizing adverse effects, which drives significant demand for accurate and reliable diagnostic tools. The growing use of complex biopharmaceuticals and biologics necessitates precise monitoring of drug levels, further boosting the TDM segment.
North America has a highly developed healthcare infrastructure, including state-of-the-art diagnostic facilities and widespread adoption of advanced technologies. Significant investments in research and development by key players and institutions in North America drive technological innovations and market growth. The region's high healthcare expenditure supports the acquisition and implementation of advanced diagnostic tools and technologies. Supportive regulatory frameworks and reimbursement policies in North America facilitate the adoption and integration of advanced diagnostic technologies.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 732.1 Mn |
|
Revenue Forecast In 2031 |
USD 1,613.6 Mn |
|
Growth Rate CAGR |
CAGR of 10.7% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, Application Type, Sample Type, Testing Type |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
Thermo Fisher Scientific Inc., Sciex, Agilent Technologies, Shimadzu Corporation, Perkinelmer, Jeol, Jasco Corporation, Teledyne Flir Llc, Mks Instruments, Analytik Jena Gmbh, Hiden Analytical, Leco, Waters Corporation, Tecan Group Ltd., Danaher Corporation, Merck Kgaa, Bio-Rad Laboratories, Inc., Perkinelmer Inc., Promega Corporation, Restek Corporation, Gerstel Gmbh & Co. KG, Phenomenex Inc., Bruker Corporation, New England Biolabs, Hamilton Company, Avantor, Inc., Chromsystems Instruments & Chemicals Gmbh, and Others |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Mass Spectrometry and Chromatography in Diagnostics Market Snapshot
Chapter 4. Global Mass Spectrometry and Chromatography in Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:
5.2.1. Sample Preparation
5.2.2. Mass Spectrometry
5.2.3. Chromatography
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Therapeutic Drug Monitoring
6.2.2. Vitamins
6.2.3. Hormones
6.2.4. Methylmalonic Acid
6.2.5. Immunosuppressants
6.2.6. Others
Chapter 7. Market Segmentation 3: by Sample Type Estimates & Trend Analysis
7.1. by Sample Type & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Sample Type:
7.2.1. Blood
7.2.2. Urine
7.2.3. Serum
7.2.4. Plasma
7.2.5. Saliva
Chapter 8. Market Segmentation 4: by Testing Type Size Estimates & Trend Analysis
8.1. By Testing Type Size & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Testing Type Size:
8.2.1. Laboratory-Developed Tests
8.2.2. Commercial Assays
Chapter 9. Mass Spectrometry and Chromatography in Diagnostics Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
9.1.2. North America Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.1.3. North America Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2024-2031
9.1.4. North America Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Testing Type Size, 2024-2031
9.1.5. North America Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
9.2.2. Europe Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.2.3. Europe Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2024-2031
9.2.4. Europe Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Testing Type Size, 2024-2031
9.2.5. Europe Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
9.3.2. Asia Pacific Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.3.3. Asia-Pacific Thermal Cyclers Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2024-2031
9.3.4. Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Testing Type Size, 2024-2031
9.3.5. Asia Pacific Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.4. Latin America
9.4.1. Latin America Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
9.4.2. Latin America Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.4.3. Latin America Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2024-2031
9.4.4. Latin America Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Testing Type Size, 2024-2031
9.4.5. Latin America Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
9.5.2. Middle East & Africa Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.5.3. Middle East & Africa Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2024-2031
9.5.4. Middle East & Africa Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Testing Type Size, 2024-2031
9.5.5. Middle East & Africa Mass Spectrometry and Chromatography in Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Thermo Fisher Scientific Inc.
10.2.2. Sciex
10.2.3. Agilent Technologies
10.2.4. Shimadzu Corporation
10.2.5. Perkinelmer
10.2.6. Jeol
10.2.7. Jasco Corporation
10.2.8. Teledyne Flir Llc
10.2.9. Mks Instruments
10.2.10. Analytik Jena Gmbh
10.2.11. Hiden Analytical
10.2.12. Leco
10.2.13. Waters Corporation
10.2.14. Tecan Group Ltd.
10.2.15. Danaher Corporation
10.2.16. Merck KGaA
10.2.17. Bio-Rad Laboratories, Inc.
10.2.18. PerkinElmer Inc.
10.2.19. Promega Corporation
10.2.20. Restek Corporation
10.2.21. Gerstel GmbH & Co. KG
10.2.22. Phenomenex Inc. (Danaher Corporation)
10.2.23. Bruker Corporation
10.2.24. New England Biolabs
10.2.25. Hamilton Company
10.2.26. Avantor, Inc. (VWR International, LLC.)
10.2.27. Chromsystems Instruments & Chemicals GmbH
Global Mass Spectrometry and Chromatography in Diagnostics Market - By Product Type
Global Mass Spectrometry and Chromatography in Diagnostics Market – By Application Type
Global Mass Spectrometry and Chromatography in Diagnostics Market – By Sample Type
Global Mass Spectrometry and Chromatography in Diagnostics Market – By Testing Type
Global Mass Spectrometry and Chromatography in Diagnostics Market – By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
